Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Achar, Jay; Seddon, James A; Knight, Gwenan M; Dodd, Peter J; Esmail, Hanif; Hughes, Jennifer; McQuaid, C Finn; (2023) Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. The European Respiratory Journal, 62 (5). p. 2300969. ISSN 0903-1936 DOI: https://doi.org/10.1183/13993003.00969-2023

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1183/13993003.00969-2023

Abstract

Share

Download

Filename: Achar_etal_2023_Guiding-pragmatic-treatment-choices.pdf

Description: This is an author accepted manuscript version of an article accepted for publication and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar